Expert Perspectives: Integrating New Data Into Best Practices for Breast Cancer

Last Modified: September 7, 2010

Conference Dates: October 1, 2010 - October 1, 2010
Conference Location: 201 Waterfront St., National Harbor, MD 20745

Sponsoring Group: Physicians' Education Resource

Conference Web Page URL:

Topics Covered:

  • Evaluate the utility of gene profiling tools in assessing recurrence risk and predicting benefit from adjuvant chemotherapy to assist decision making for early-stage breast cancer.
  • Examine the adjuvant chemotherapy options for patients with early-stage, triple-negative breast cancer.
  • Discuss the latest clinical data on adjuvant HER2-targeted therapy, including patient selection and management of associated toxicities.
  • Assess the efficacy and safety of cytotoxic agents and targeted therapies, or combinations of both, in patients with advanced triple-negative breast cancer.
  • Review standard and novel therapeutic options for patients with HER2-overexpressing metastatic breast cancer, including combinatorial therapies and options beyond progression on standard therapy.
  • Guide patients with breast cancer to promising clinical trials.

Who Should Attend: medical oncologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals

Registration Information: For registration assistance, please email, or call (888) 949-0045

Conference Fees: Free

Continuing Education: Yes



7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015